Guarana

Guarana is a botanical ingredient derived from the seeds of the Paullinia cupana plant, native to the Amazon rainforest. It is one of the most familiar and commercially understood natural energy ingredients across EU and US markets, valued for its sustained-release caffeine profile that provides alertness without the sharp peaks and crashes associated with isolated caffeine.

For private-label gummy brands, Guarana offers a clean-label positioning as a plant-based energy source. Its low cost tier and good gummy applicability make it an accessible active for brands targeting natural energy, mental focus, and pre-workout positioning. Because Guarana is a botanical on the EFSA on-hold list, brands must rely on co-formulated nutrients such as Vitamin B6, B12, or Magnesium to carry authorised energy-yielding metabolism claims on pack.

Origin and history

Guarana has been used for centuries by indigenous Amazonian tribes, particularly the Sateré-Maué people of Brazil, who prepared a paste from the seeds for its stimulating and medicinal properties. The plant was introduced to European markets in the 19th century and became popular in Brazil as a soft drink ingredient, where it remains a national staple.

Today, Guarana is cultivated primarily in Brazil, with smaller production in Venezuela and Colombia. The seeds are harvested, dried, and processed into either a fine powder or a standardised extract. Industrial production focuses on standardising caffeine content to ensure batch-to-batch consistency, typically ranging from 10% to 22% caffeine by weight.

Scientific overview

The primary active compound in Guarana is caffeine, known in this context as guaranine. Unlike synthetic caffeine, Guarana contains a complex matrix of other xanthines (theobromine, theophylline) and tannins that modulate its absorption and metabolism, resulting in a more gradual release of caffeine into the bloodstream. This sustained-release profile is the key differentiator from isolated caffeine sources.

Bioavailability of Guarana's caffeine is comparable to synthetic caffeine, but the presence of tannins may slow gastric emptying and prolong the absorption phase. Standardised extracts provide predictable caffeine content, while whole seed powder offers the full phytochemical profile but with less precise dosing. For gummy manufacturing, standardised extracts are preferred for consistent potency and reduced bitterness.

Manufacturing watchpoints include the bitter astringent taste, which requires robust flavour masking with sweet profiles such as berry, tropical fruit, or citrus. Guarana is heat-stable and soluble in gummy matrices, making it straightforward to incorporate. Cost-per-mg is low, particularly when compared to synthetic caffeine alternatives, though standardised extracts command a slight premium over raw powder.

Guarana occupies a strong position in the natural energy segment, appealing to consumers seeking plant-based alternatives to synthetic caffeine. It is commonly positioned alongside L-Theanine for smooth focus, Ginseng for adaptogenic energy, or CoQ10 for mitochondrial support. The sustained-release profile is a key selling point for brands targeting sustained mental alertness without jitters.

From a formulation and manufacturing perspective, Guarana is one of the most straightforward botanicals to work with in gummies. It is heat-stable, soluble, and compatible with standard gummy processing temperatures. The primary challenge is taste — the bitter astringency requires careful flavour engineering, typically with high-intensity sweeteners and fruit flavours. DAT's formulation team can recommend masking strategies per project.

For pack copy, brands should position Guarana around natural energy and mental alertness without making specific health claims. Because Guarana has no authorised claims under applicable claims framework, any health-related wording must be carried by co-formulated nutrients such as Vitamin B6 (contributes to normal energy-yielding metabolism) or Magnesium (contributes to normal functioning of the nervous system). DAT reviews claim strategy per project to ensure compliance with EU and UK regulations.